Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others), By Drug Class (Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds, Antimicrobials), By Route of Administration (Oral, Powder Inhalation, Intravenous Administration), By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi), By Application (Prevention, Treatment of Malaria), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others), By Region, Forecast & Opportunities, 2028

December 2022 | 115 pages | ID: G56F226A753FEN
TechSci Research

Abstracts

Global antimalarial drugs market is expected to register impressive growth during the forecast period, 2024-2028. Increasing prevalence of malaria coupled with surge in research for new antimalarial drugs is anticipated to propel the growth of the market. According to the “World Malaria Report 2021” by World Health Organization (WHO), in 2020, there were approximately 228 million cases and about 6,02,000 malaria-related deaths. Moreover, the increase in awareness initiatives by governments is also a key factor for growth of antimalarial drugs market. In 2021, the government of Malawi launched a 'Zero Malaria Starts with Me' campaign to stop malaria by the year 2030, which is the leading cause of death in Malawi.

Additionally, rise in malaria death cases, especially in developing nations are also fueling the growth of antimalarial drugs market. According to World Health Organization (WHO), about half of the world's population is at risk of malaria.

Global antimalarial drugs market can be segmented based on drug type, drug class, route of administration, malaria type, application, distribution channel, company, and region. Based on drug class, the market is segmented into aryl aminoalcohol compounds, antifolate compounds, artemisinin compounds and antimicrobials. Among them, the aryl aminoalcohol compounds segment is expected to witness high growth during the forecast period owing to rising cases of malaria across the world.

Based on route of administration, the global antimalarial drugs market is segmented into oral, powder inhalation and intravenous administration. Among them, the oral segment is expected to undergo high growth through 2028 owing to the advantages such as safety, easy ingestion, pain avoidance and better patient compliance.

Major companies operating in global antimalarial drugs market include Cipla Ltd, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Merck & Co., Inc, Novartis AG, Zydus Cadila, Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), Strides Pharma Science Limited, Glenmark Pharmaceuticals Ltd., and Lincoln Pharmaceuticals Ltd. The market players are adopting growth strategies like new product launches, mergers & partnerships to increase their global market share.

Objective of the Study:

• To analyze and forecast the market size of global antimalarial drugs market.
• To forecast global antimalarial drugs market based on drug type, drug class, route of administration, malaria type, application, distribution channel, company and regional distribution.
• To identify drivers and challenges for global antimalarial drugs market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global antimalarial drugs market.
• To identify and analyse the profile of leading players operating in the global antimalarial drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of antimalarial drugs companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global antimalarial drugs market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

• Antimalarial drugs companies/partners, investors, and other stakeholders
• Hospital pharmacy/ retail pharmacy
• Government bodies such as regulating authorities and policy makers
• Organizations, industry associations, forums and alliances related to antimalarial drugs
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as antimalarial drugs vendors, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global antimalarial drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global Antimalarial Drugs Market, By Drug Type:
• Quinine
• Chloroquine
• Proguanil
• Amodiaquine
• Mefloquine
• Hydroxychloroquine
• Pyrimethamine
• Others
• Global Antimalarial Drugs Market, By Drug Class:
• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds
• Antimicrobials
• Global Antimalarial Drugs Market, By Route of Administration:
• Oral
• Powder Inhalation
• Intravenous Administration
• Global Antimalarial Drugs Market, By Malaria Type:
• Plasmodium Falciparum
• Plasmodium Malariae
• Plasmodium Vivax
• Plasmodium Ovale
• Plasmodium Knowlesi
• Global Antimalarial Drugs Market, By Application:
• Prevention
• Treatment of Malaria
• Global Antimalarial Drugs Market, By Distribution Channel:
• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce
• Others
• Global Antimalarial Drugs Market, By Region:
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Singapore
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• North America
• United States
• Mexico
• Canada
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global antimalarial drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

• Profit margin analysis in case of direct and indirect sales channel.

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. CLINICAL TRIAL ANALYSIS

5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Country
5.8. Clinical Trials Heat Map

6. GLOBAL ANTIMALARIAL DRUGS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value & Volume
6.2. Market Share & Forecast
  6.2.1. By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others)
  6.2.2. By Drug Class (Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds, Antimicrobials)
  6.2.3. By Route of Administration (Oral, Powder Inhalation, Intravenous Administration)
  6.2.4. By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi)
  6.2.5. By Application (Prevention, Treatment of Malaria)
  6.2.6. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others)
  6.2.7. By Company (2022)
  6.2.8. By Region
6.3. Product Market Map

7. ASIA-PACIFIC ANTIMALARIAL DRUGS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value & Volume
7.2. Market Share & Forecast
  7.2.1. By Drug Type
  7.2.2. By Drug Class
  7.2.3. By Route of Administration
  7.2.4. By Malaria Type
  7.2.5. By Application
  7.2.6. By Distribution Channel
  7.2.7. By Country
7.3. Asia-Pacific: Country Analysis
  7.3.1. China Antimalarial Drugs Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value & Volume
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Drug Type
      7.3.1.2.2. By Drug Class
      7.3.1.2.3. By Route of Administration
      7.3.1.2.4. By Malaria Type
      7.3.1.2.5. By Application
      7.3.1.2.6. By Distribution Channel
  7.3.2. India Antimalarial Drugs Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value & Volume
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Drug Type
      7.3.2.2.2. By Drug Class
      7.3.2.2.3. By Route of Administration
      7.3.2.2.4. By Malaria Type
      7.3.2.2.5. By Application
      7.3.2.2.6. By Distribution Channel
  7.3.3. Japan Antimalarial Drugs Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value & Volume
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Drug Type
      7.3.3.2.2. By Drug Class
      7.3.3.2.3. By Route of Administration
      7.3.3.2.4. By Malaria Type
      7.3.3.2.5. By Application
      7.3.3.2.6. By Distribution Channel
  7.3.4. South Korea Antimalarial Drugs Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value & Volume
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Drug Type
      7.3.4.2.2. By Drug Class
      7.3.4.2.3. By Route of Administration
      7.3.4.2.4. By Malaria Type
      7.3.4.2.5. By Application
      7.3.4.2.6. By Distribution Channel
  7.3.5. Singapore Antimalarial Drugs Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value & Volume
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Drug Type
      7.3.5.2.2. By Drug Class
      7.3.5.2.3. By Route of Administration
      7.3.5.2.4. By Malaria Type
      7.3.5.2.5. By Application
      7.3.5.2.6. By Distribution Channel
  7.3.6. Australia Antimalarial Drugs Market Outlook
    7.3.6.1. Market Size & Forecast
      7.3.6.1.1. By Value & Volume
    7.3.6.2. Market Share & Forecast
      7.3.6.2.1. By Drug Type
      7.3.6.2.2. By Drug Class
      7.3.6.2.3. By Route of Administration
      7.3.6.2.4. By Malaria Type
      7.3.6.2.5. By Application
      7.3.6.2.6. By Distribution Channel

8. EUROPE ANTIMALARIAL DRUGS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value & Volume
8.2. Market Share & Forecast
  8.2.1. By Drug Type
  8.2.2. By Drug Class
  8.2.3. By Route of Administration
  8.2.4. By Malaria Type
  8.2.5. By Application
  8.2.6. By Distribution Channel
  8.2.7. By Country
8.3. Europe: Country Analysis
  8.3.1. France Antimalarial Drugs Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value & Volume
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Drug Type
      8.3.1.2.2. By Drug Class
      8.3.1.2.3. By Route of Administration
      8.3.1.2.4. By Malaria Type
      8.3.1.2.5. By Application
      8.3.1.2.6. By Distribution Channel
  8.3.2. Germany Antimalarial Drugs Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value & Volume
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Drug Type
      8.3.2.2.2. By Drug Class
      8.3.2.2.3. By Route of Administration
      8.3.2.2.4. By Malaria Type
      8.3.2.2.5. By Application
      8.3.2.2.6. By Distribution Channel
  8.3.3. United Kingdom Antimalarial Drugs Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value & Volume
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Drug Type
      8.3.3.2.2. By Drug Class
      8.3.3.2.3. By Route of Administration
      8.3.3.2.4. By Malaria Type
      8.3.3.2.5. By Application
      8.3.3.2.6. By Distribution Channel
  8.3.4. Italy Antimalarial Drugs Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value & Volume
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Drug Type
      8.3.4.2.2. By Drug Class
      8.3.4.2.3. By Route of Administration
      8.3.4.2.4. By Malaria Type
      8.3.4.2.5. By Application
      8.3.4.2.6. By Distribution Channel
  8.3.5. Spain Antimalarial Drugs Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value & Volume
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Drug Type
      8.3.5.2.2. By Drug Class
      8.3.5.2.3. By Route of Administration
      8.3.5.2.4. By Malaria Type
      8.3.5.2.5. By Application
      8.3.5.2.6. By Distribution Channel

9. NORTH AMERICA ANTIMALARIAL DRUGS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value & Volume
9.2. Market Share & Forecast
  9.2.1. By Drug Type
  9.2.2. By Drug Class
  9.2.3. By Route of Administration
  9.2.4. By Malaria Type
  9.2.5. By Application
  9.2.6. By Distribution Channel
  9.2.7. By Country
9.3. North America: Country Analysis
  9.3.1. United States Antimalarial Drugs Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value & Volume
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Drug Type
      9.3.1.2.2. By Drug Class
      9.3.1.2.3. By Route of Administration
      9.3.1.2.4. By Malaria Type
      9.3.1.2.5. By Application
      9.3.1.2.6. By Distribution Channel
  9.3.2. Mexico Antimalarial Drugs Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value & Volume
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Drug Type
      9.3.2.2.2. By Drug Class
      9.3.2.2.3. By Route of Administration
      9.3.2.2.4. By Malaria Type
      9.3.2.2.5. By Application
      9.3.2.2.6. By Distribution Channel
  9.3.3. Canada Antimalarial Drugs Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value & Volume
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Drug Type
      9.3.3.2.2. By Drug Class
      9.3.3.2.3. By Route of Administration
      9.3.3.2.4. By Malaria Type
      9.3.3.2.5. By Application
      9.3.3.2.6. By Distribution Channel

10. SOUTH AMERICA ANTIMALARIAL DRUGS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value & Volume
10.2. Market Share & Forecast
  10.2.1. By Drug Type
  10.2.2. By Drug Class
  10.2.3. By Route of Administration
  10.2.4. By Malaria Type
  10.2.5. By Application
  10.2.6. By Distribution Channel
  10.2.7. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Antimalarial Drugs Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value & Volume
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Drug Type
      10.3.1.2.2. By Drug Class
      10.3.1.2.3. By Route of Administration
      10.3.1.2.4. By Malaria Type
      10.3.1.2.5. By Application
      10.3.1.2.6. By Distribution Channel
  10.3.2. Argentina Antimalarial Drugs Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value & Volume
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Drug Type
      10.3.2.2.2. By Drug Class
      10.3.2.2.3. By Route of Administration
      10.3.2.2.4. By Malaria Type
      10.3.2.2.5. By Application
      10.3.2.2.6. By Distribution Channel
  10.3.3. Colombia Antimalarial Drugs Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value & Volume
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Drug Type
      10.3.3.2.2. By Drug Class
      10.3.3.2.3. By Route of Administration
      10.3.3.2.4. By Malaria Type
      10.3.3.2.5. By Application
      10.3.3.2.6. By Distribution Channel

11. MIDDLE EAST AND AFRICA ANTIMALARIAL DRUGS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value & Volume
11.2. Market Share & Forecast
  11.2.1. By Drug Type
  11.2.2. By Drug Class
  11.2.3. By Route of Administration
  11.2.4. By Malaria Type
  11.2.5. By Application
  11.2.6. By Distribution Channel
  11.2.7. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Antimalarial Drugs Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value & Volume
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Drug Type
      11.3.1.2.2. By Drug Class
      11.3.1.2.3. By Route of Administration
      11.3.1.2.4. By Malaria Type
      11.3.1.2.5. By Application
      11.3.1.2.6. By Distribution Channel
  11.3.2. Saudi Arabia Antimalarial Drugs Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value & Volume
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Drug Type
      11.3.2.2.2. By Drug Class
      11.3.2.2.3. By Route of Administration
      11.3.2.2.4. By Malaria Type
      11.3.2.2.5. By Application
      11.3.2.2.6. By Distribution Channel
  11.3.3. UAE Antimalarial Drugs Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value & Volume
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Drug Type
      11.3.3.2.2. By Drug Class
      11.3.3.2.3. By Route of Administration
      11.3.3.2.4. By Malaria Type
      11.3.3.2.5. By Application
      11.3.3.2.6. By Distribution Channel

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
  14.2.1. Cipla Ltd
  14.2.2. GlaxoSmithKline Plc
  14.2.3. Ipca Laboratories Ltd.
  14.2.4. Merck & Co., Inc
  14.2.5. Novartis AG
  14.2.6. Zydus Cadila
  14.2.7. Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories)
  14.2.8. Strides Pharma Science Limited
  14.2.9. Glenmark Pharmaceuticals Ltd.
  14.2.10. Lincoln Pharmaceuticals Ltd.

15. STRATEGIC RECOMMENDATIONS